Lichen planopilaris treated by the peroxisome proliferator activated receptor-? agonist pioglitazone: Lack of lasting improvement or cure in the majority of patients - 23/10/13

Philipp Spring, MD ^a, Zoi Spanou, MD ^b, Pierre A. de Viragh, MD ^{a, b, c, ⁎}

^a Dermatology University Clinic, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland 

^b Dermatology University Clinic, Inselspital, Bern, Switzerland 

^c Private practice, Zurich, Switzerland 

^∗Correspondence to: Pierre de Viragh, MD, Schanzeneggstr. 1, 8002 Zurich/Switzerland